Cuorips Inc. (TYO:4894)

Japan flag Japan · Delayed Price · Currency is JPY
6,010.00
+10.00 (0.17%)
Jun 13, 2025, 3:30 PM JST
-12.39%
Market Cap 48.64B
Revenue (ttm) 175.00M
Net Income (ttm) -644.00M
Shares Out 8.09M
EPS (ttm) -80.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 138,100
Average Volume 159,415
Open 6,100.00
Previous Close 6,010.00
Day's Range 5,980.00 - 6,110.00
52-Week Range 4,145.00 - 10,050.00
Beta 0.71
RSI 41.80
Earnings Date Aug 13, 2025

About Cuorips

Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 59
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4894
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.